Extrarenal effects of aldosterone and antimineralocorticoid compounds.
Moura
A M
AM
Centre de Recherches Roussel-Uclaf, Romainville, France.
Angeli
M
M
Worcel
M
M
D000450:Aldosterone / Q000494:pharmacology*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D015221:Potassium Channels / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D015222:Sodium Channels / Q000187:drug effects; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014667:Vasopressins / Q000502:physiology
D000451:Mineralocorticoid Receptor Antagonists; D015221:Potassium Channels; D015222:Sodium Channels; D014667:Vasopressins; D013148:Spironolactone; D000450:Aldosterone; C041006:RU 28318